{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:30Z","timestamp":1707524670556},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,6]]},"DOI":"10.7759\/cureus.28825","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T09:02:03Z","timestamp":1662454923000},"source":"Crossref","is-referenced-by-count":0,"title":["Non-Mucormycetes Causes of Fungal Rhino Sinusitis With Periocular Swelling in COVID-19 With Delta Variant"],"prefix":"10.7759","author":[{"given":"Anita","family":"Ambasta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakhi","family":"Kusumesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamlesh","family":"Rajpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taab154","article-title":"Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta with individuals sera vaccinated with BBV152","volume":"28","author":"Yadav PD","year":"2021","unstructured":"Yadav PD, Sahay RR, Sapkal G, et al.. Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta with individuals sera vaccinated with BBV152. J Travel Med. 2021, 28:10.1093\/jtm\/taab154","journal-title":"J Travel Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_3774_20","article-title":"Mucor in a viral land: a tale of two pathogens","volume":"69","author":"Sen M","year":"2021","unstructured":"Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: a tale of two pathogens. Indian J Ophthalmol. 2021, 69:244-52. 10.4103\/ijo.IJO_3774_20","journal-title":"Indian J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.11124.1","article-title":"Rare fungal infectious agents: a lurking enemy","volume":"6","author":"Skiada A","year":"2017","unstructured":"Skiada A, Pavleas I, Drogari-Apiranthitou M. Rare fungal infectious agents: a lurking enemy. F1000Res. 2017, 6:1917. 10.12688\/f1000research.11124.1","journal-title":"F1000Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw B","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, et al.. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008, 46:1813-21. 10.1086\/588660","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020201473","article-title":"CO-RADS: A categorical CT assessment scheme for patients suspected of having COVID-19-definition and evaluation","volume":"296","author":"Prokop M","year":"2020","unstructured":"Prokop M, van Everdingen W, van Rees Vellinga T, et al.. CO-RADS: A categorical CT assessment scheme for patients suspected of having COVID-19-definition and evaluation. Radiology. 2020, 296:E97-E104. 10.1148\/radiol.2020201473","journal-title":"Radiology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely OA","year":"2019","unstructured":"Cornely OA, Alastruey-Izquierdo A, Arenz D, et al.. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019, 19:e405-21. 10.1016\/S1473-3099(19)30312-3","journal-title":"Lancet Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj9932","article-title":"Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India","volume":"374","author":"Dhar MS","year":"2021","unstructured":"Dhar MS, Marwal R, Vs R, et al.. Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India. Science. 2021, 374:995-9. 10.1126\/science.abj9932","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jof7070556","article-title":"Epidemiology of systemic mycoses in the COVID-19 pandemic","volume":"7","author":"Fr\u00edas-De-Le\u00f3n MG","year":"2021","unstructured":"Fr\u00edas-De-Le\u00f3n MG, Pinto-Almaz\u00e1n R, Hern\u00e1ndez-Castro R, et al.. Epidemiology of systemic mycoses in the COVID-19 pandemic. J Fungi (Basel). 2021, 7:10.3390\/jof7070556","journal-title":"J Fungi (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19: we should be prepared","volume":"30","author":"Gangneux JP","year":"2020","unstructured":"Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR. Invasive fungal diseases during COVID-19: we should be prepared. J Mycol Med. 2020, 30:100971. 10.1016\/j.mycmed.2020.100971","journal-title":"J Mycol Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/IPC.0000000000000607","article-title":"A case of fatal Penicillium rhinosinusitis in a patient with acute myelogenous leukemia and prolonged neutropenia","volume":"26","author":"Shah N","year":"2018","unstructured":"Shah N, Midha S, Nanjappa S, Greene J. A case of fatal Penicillium rhinosinusitis in a patient with acute myelogenous leukemia and prolonged neutropenia. Infect Dis Clin Pract. 2018, 26:1-3. 10.1097\/IPC.0000000000000607","journal-title":"Infect Dis Clin Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.08.024","article-title":"Perplexity of a fungus in the sinus","volume":"127","author":"Dasararaju R","year":"2014","unstructured":"Dasararaju R, Many WJ, Samant JS. Perplexity of a fungus in the sinus. Am J Med. 2014, 127:e1-2. 10.1016\/j.amjmed.2013.08.024","journal-title":"Am J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.009","article-title":"Differences between first wave and second wave of COVID-19 in India","volume":"15","author":"Jain VK","year":"2021","unstructured":"Jain VK, Iyengar KP, Vaishya R. Differences between first wave and second wave of COVID-19 in India. Diabetes Metab Syndr. 2021, 15:1047-8. 10.1016\/j.dsx.2021.05.009","journal-title":"Diabetes Metab Syndr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"Petrilli CM","year":"2020","unstructured":"Petrilli CM, Jones SA, Yang J, et al.. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020, 369:m1966. 10.1136\/bmj.m1966","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2021.1903044","article-title":"Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19","volume":"41","author":"Dallalzadeh LO","year":"2022","unstructured":"Dallalzadeh LO, Ozzello DJ, Liu CY, Kikkawa DO, Korn BS. Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19. Orbit. 2022, 41:616-9. 10.1080\/01676830.2021.1903044","journal-title":"Orbit"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3342\/ceo.2014.7.3.181","article-title":"Invasive fungal sinusitis of the sphenoid sinus","volume":"7","author":"Lee DH","year":"2014","unstructured":"Lee DH, Yoon TM, Lee JK, Joo YE, Park KH, Lim SC. Invasive fungal sinusitis of the sphenoid sinus. Clin Exp Otorhinolaryngol. 2014, 7:181-7. 10.3342\/ceo.2014.7.3.181","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/1793-5482.144188","article-title":"Invasive aspergillus sinusitis with orbitocranial extension","volume":"12","author":"Baeesa SS","year":"2017","unstructured":"Baeesa SS, Bokhari RF, Alghamdi KB, Alem HB, Al-Maghrabi JA, Madani TA. Invasive aspergillus sinusitis with orbitocranial extension. Asian J Neurosurg. 2017, 12:172-9. 10.4103\/1793-5482.144188","journal-title":"Asian J Neurosurg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14280","article-title":"Third cranial nerve palsy due to COVID-19 infection","volume":"13","author":"Douedi S","year":"2021","unstructured":"Douedi S, Naser H, Mazahir U, Hamad AI, Sedarous M. Third cranial nerve palsy due to COVID-19 infection. Cureus. 2021, 13:e14280. 10.7759\/cureus.14280","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/lary.29632","article-title":"Invasive fungal sinusitis in post COVID-19 patients: a new clinical entity","volume":"131","author":"El-Kholy NA","year":"2021","unstructured":"El-Kholy NA, El-Fattah AM, Khafagy YW. Invasive fungal sinusitis in post COVID-19 patients: a new clinical entity. Laryngoscope. 2021, 131:2652-8. 10.1002\/lary.29632","journal-title":"Laryngoscope"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18827","article-title":"Risk of mucormycosis in diabetes mellitus: a systematic review","volume":"13","author":"Khanna M","year":"2021","unstructured":"Khanna M, Challa S, Kabeil AS, et al.. Risk of mucormycosis in diabetes mellitus: a systematic review. Cureus. 2021, 13:e18827. 10.7759\/cureus.18827","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1148\/rg.275065189","article-title":"Imaging features of invasive and noninvasive fungal sinusitis: a review","volume":"27","author":"Aribandi M","year":"2007","unstructured":"Aribandi M, McCoy VA, Bazan C 3rd. Imaging features of invasive and noninvasive fungal sinusitis: a review. Radiographics. 2007, 27:1283-96. 10.1148\/rg.275065189","journal-title":"Radiographics"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht R","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, et al.. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002, 347:408-15. 10.1056\/NEJMoa020191","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.s3329","article-title":"Posaconazole in the management of refractory invasive fungal infections","volume":"4","author":"Langner S","year":"2008","unstructured":"Langner S, Staber PB, Neumeister P. Posaconazole in the management of refractory invasive fungal infections. Ther Clin Risk Manag. 2008, 4:747-58. 10.2147\/tcrm.s3329","journal-title":"Ther Clin Risk Manag"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00014-07","article-title":"Fusarium infections in immunocompromised patients","volume":"20","author":"Nucci M","year":"2007","unstructured":"Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007, 20:695-704. 10.1128\/CMR.00014-07","journal-title":"Clin Microbiol Rev"},{"key":"ref24","article-title":"Update on the treatment of disseminated fusariosis: Focus on voriconazole","volume":"3","author":"Stanzani M","year":"2007","unstructured":"Stanzani M, Tumietto F, Vianelli N, Baccarani M. Update on the treatment of disseminated fusariosis: Focus on voriconazole. Ther Clin Risk Manag. 2007, 3:1165-73.","journal-title":"Ther Clin Risk Manag"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4161\/viru.2.2.15015","article-title":"The challenge of managing fusariosis","volume":"2","author":"Muhammed M","year":"2011","unstructured":"Muhammed M, Coleman JJ, Carneiro HA, Mylonakis E. The challenge of managing fusariosis. Virulence. 2011, 2:91-6. 10.4161\/viru.2.2.15015","journal-title":"Virulence"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13334","article-title":"Mucormycosis in patients with COVID-19: a cross-sectional descriptive multicentre study from Iran","volume":"64","author":"Pakdel F","year":"2021","unstructured":"Pakdel F, Ahmadikia K, Salehi M, et al.. Mucormycosis in patients with COVID-19: a cross-sectional descriptive multicentre study from Iran. Mycoses. 2021, 64:1238-52. 10.1111\/myc.13334","journal-title":"Mycoses"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.11.2407","article-title":"Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens","volume":"37","author":"Supparatpinyo K","year":"1993","unstructured":"Supparatpinyo K, Nelson KE, Merz WG, Breslin BJ, Cooper CR Jr, Kamwan C, Sirisanthana T. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrob Agents Chemother. 1993, 37:2407-11. 10.1128\/AAC.37.11.2407","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(87)90111-8","article-title":"Human Curvularia infections. Report of five cases and review of the literature","volume":"6","author":"Rinaldi MG","year":"1987","unstructured":"Rinaldi MG, Phillips P, Schwartz JG, et al.. Human Curvularia infections. Report of five cases and review of the literature. Diagn Microbiol Infect Dis. 1987, 6:27-39. 10.1016\/0732-8893(87)90111-8","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.02.034","article-title":"In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia","volume":"76","author":"da Cunha KC","year":"2013","unstructured":"da Cunha KC, Sutton DA, Fothergill AW, et al.. In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia. Diagn Microbiol Infect Dis. 2013, 76:168-74. 10.1016\/j.diagmicrobio.2013.02.034","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/96850-non-mucormycetes-causes-of-fungal-rhino-sinusitis-with-periocular-swelling-in-covid-19-with-delta-variant","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:01Z","timestamp":1707507661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/96850-non-mucormycetes-causes-of-fungal-rhino-sinusitis-with-periocular-swelling-in-covid-19-with-delta-variant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.28825","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,6]]}}}